Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Uromodulin as a genetically anchored biomarker stratifies time to valve intervention in aortic regurgitation.

Frontiers in cardiovascular medicine·2026
Same author

<i>Arthrospira platensis</i> Mitigates LPA-Induced Endothelial Dysfunction: A Prospective, Placebo-Controlled Study.

Cells·2026
Same author

A comprehensive review of GLP-1 and aerobic training in cardiovascular disease management.

Clinical hemorheology and microcirculation·2026
Same author

Improvement of functional mitral and tricuspid regurgitation in patients with atrial fibrillation after sinus rhythm restoration-the Berlin FMTR registry.

Clinical research in cardiology : official journal of the German Cardiac Society·2026
Same author

A novel spacer for transcatheter treatment of tricuspid regurgitation.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026
Same author

Editorial: pacing after transcatheter tricuspid valve replacement: where are we going, where do we stand?

European heart journal. Case reports·2026

Related Experiment Video

Updated: Jan 5, 2026

In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

1.1K

In Vitro Thrombogenicity Testing of Biomaterials.

Steffen Braune1, Robert A Latour2, Markus Reinthaler1,3

  • 1Institute of Biomaterial Science and Berlin-Brandenburg Centre for Regenerative Therapies (BCRT), Helmholtz-Zentrum Geesthacht, Kantstrasse 55, 14513, Teltow, Germany.

Advanced Healthcare Materials
|October 16, 2019
PubMed
Summary

Predicting the blood clot risk of implant materials remains difficult. This review examines in vitro thrombogenicity testing methods for biomaterials to improve cardiovascular disease treatments.

Keywords:
biomaterialsblood testsimplantsin vitrothrombogenicity

More Related Videos

Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow
09:41

Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow

Published on: March 5, 2020

10.0K
An In Vitro Hemodynamic Loop Model to Investigate the Hemocytocompatibility and Host Cell Activation of Vascular Medical Devices
08:44

An In Vitro Hemodynamic Loop Model to Investigate the Hemocytocompatibility and Host Cell Activation of Vascular Medical Devices

Published on: August 21, 2020

7.7K

Related Experiment Videos

Last Updated: Jan 5, 2026

In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

1.1K
Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow
09:41

Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow

Published on: March 5, 2020

10.0K
An In Vitro Hemodynamic Loop Model to Investigate the Hemocytocompatibility and Host Cell Activation of Vascular Medical Devices
08:44

An In Vitro Hemodynamic Loop Model to Investigate the Hemocytocompatibility and Host Cell Activation of Vascular Medical Devices

Published on: August 21, 2020

7.7K

Area of Science:

  • Biomaterials Science
  • Cardiovascular Research
  • Medical Device Engineering

Background:

  • The thrombogenicity of implant materials is unpredictable, posing a challenge for cardiovascular disease treatment.
  • Understanding the interaction between medical devices and biological systems is crucial for developing effective biofunctional materials.
  • Standardized in vitro testing methods are needed for reproducible categorization of biomaterial thrombogenicity.

Purpose of the Study:

  • To review the current status of in vitro thrombogenicity testing methods for biomaterials.
  • To highlight the importance of standardized approaches for reproducible testing.
  • To discuss future perspectives for disease-oriented in vitro thrombogenicity testing.

Main Methods:

  • Review of existing literature on in vitro thrombogenicity testing.
  • Analysis of test material and reference preparation.
  • Evaluation of donor and blood sample selection and characterization.
  • Assessment of prerequisites for reproducible testing and applied test systems.

Main Results:

  • Current in vitro thrombogenicity testing methods require further standardization for reproducibility.
  • Joint efforts are underway to establish common standards for biomaterial testing.
  • There is a need for more disease-oriented approaches in thrombogenicity testing.

Conclusions:

  • Standardized and reproducible in vitro thrombogenicity testing is essential for advancing cardiovascular device development.
  • Further research and collaboration are needed to refine testing methodologies.
  • Developing disease-oriented tests will lead to more accurate predictions of in vivo performance.